Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It is advancing a pipeline of both native and engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. Its advanced product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy designed to provide transformative treatment options. AgenT-797 is an iNKT cell therapy that harnesses the dual power of innate and adaptive immunity. In addition, it is advancing a pipeline of allogeneic, engineered iNKT programs. Its two advanced preclinical engineered programs are MiNK-413, an IL-15 armored CAR-iNKT program targeting B cell maturation antigen (BCMA), and MiNK-215, an IL-15 armored tumor stromal targeting FAP-CAR-iNKT program.
Find out what a historical investment in MINK THERAPEUTICS, INC. would be worth today using our INKT stock calculator.
Buying INKT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in MINK THERAPEUTICS, INC. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in INKT
What is the ticker symbol of MINK THERAPEUTICS, INC.?
The ticker symbol for MINK THERAPEUTICS, INC. is INKT.
How much is one share of INKT?
One share of INKT is valued at $8.02 as of 21 November 2026.
What is the market capitalisation of MINK THERAPEUTICS, INC. INKT?
As of 21 November 2026 MINK THERAPEUTICS, INC. has a market cap of $41.17M.
What is the 52-week high for MINK THERAPEUTICS, INC. stock?
The MINK THERAPEUTICS, INC. 52-week high stock price is $16.93.
What is the 52-week low for MINK THERAPEUTICS, INC. stock?
The MINK THERAPEUTICS, INC. 52-week low stock price is $8.48.
Can I buy INKT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy INKT shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in INKT on Stake
Buy INKT from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of INKT from only US$10 with fractional shares